These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33364828)

  • 21. Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction.
    Wei ZJ; Qiao YT; Zhou BC; Rankine AN; Zhang LX; Su YZ; Xu AM; Han WX; Luo PQ
    World J Gastrointest Surg; 2022 Aug; 14(8):788-798. PubMed ID: 36157366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
    Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
    Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of laparoscopic gastrectomy for patients with Siewert-type II/III adenocarcinoma of the esophagogastric junction: A propensity score matching analysis.
    Shi Y; Li L; Xiao H; Guo S; Wang G; Tao K; Dong J; Zong L
    PLoS One; 2018; 13(9):e0203125. PubMed ID: 30256806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction.
    Zhang L; Su Y; Chen Z; Wei Z; Han W; Xu A
    Medicine (Baltimore); 2017 Jul; 96(30):e7647. PubMed ID: 28746229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study.
    Huang CM; Lv CB; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
    Surg Endosc; 2017 Sep; 31(9):3495-3503. PubMed ID: 27981384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of examined lymph node number on accurate nodal staging and long-term survival of resected Siewert type II-III adenocarcinoma of the esophagogastric junction: A large population-based study.
    Ding B; Yong J; Zhang L; Luo P; Song E; Rankine AN; Wei Z; Wang X; Xu A
    Front Oncol; 2022; 12():979338. PubMed ID: 36387223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term oncological outcomes of laparoscopic versus open transhiatal resection for patients with Siewert type II adenocarcinoma of the esophagogastric junction.
    Sugita S; Kinoshita T; Kuwata T; Tokunaga M; Kaito A; Watanabe M; Tonouchi A; Sato R; Nagino M
    Surg Endosc; 2021 Jan; 35(1):340-348. PubMed ID: 32025923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
    Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
    Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Five-step maneuver of transthoracic single-port assisted laparoscopic lower mediastinal lymph node dissection for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
    Luo SJ; Xiong WW; Chen Y; Li ZY; Li E; Zeng HP; Zheng YS; Luo LJ; Li J; Cui ZM; Wan J; Wang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Aug; 24(8):684-690. PubMed ID: 34412185
    [No Abstract]   [Full Text] [Related]  

  • 32. The Impact of Lymphovascular Invasion on Risk of Upstaging and Lymph Node Metastasis at the Time of Radical Cystectomy.
    Werntz RP; Smith ZL; Packiam VT; Smith N; Steinberg GD
    Eur Urol Focus; 2020 Mar; 6(2):292-297. PubMed ID: 30297221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Patterns and influencing factors of lymph node metastasis of adenocarcinoma of the esophagogastric junction in 393 patients].
    Zhang YJ; Wang J; Zhang XL; Liu Q; Jing SW; Wang Y; Cao F; Jiao WP
    Zhonghua Zhong Liu Za Zhi; 2016 Sep; 38(9):672-6. PubMed ID: 27647399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction.
    Reynolds JV; Ravi N; Muldoon C; Larkin JO; Rowley S; O'Byrne K; Hollywood D; O'Toole D
    World J Surg; 2010 Dec; 34(12):2821-9. PubMed ID: 20827475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of outcomes after surgery between adenocarcinoma of the esophagogastric junction and lower thoracic esophageal squamous cell cancer].
    Fu SJ; Fang WT; Mao T; Feng J; Gu ZT; Chen WH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Sep; 15(9):893-6. PubMed ID: 22990917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a novel staging classification for Siewert II adenocarcinoma of the esophagogastric junction after neoadjuvant chemotherapy.
    Zhang J; Liu H; Yu H; Xu WX
    World J Gastrointest Oncol; 2024 Jun; 16(6):2541-2554. PubMed ID: 38994140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma.
    Wu XN; Liu CQ; Tian JY; Guo MF; Xu MQ
    Int J Surg; 2017 May; 41():6-11. PubMed ID: 28323156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative monocyte-lymphocyte and neutrophil-lymphocyte but not platelet-lymphocyte ratios are predictive of clinical outcomes in resected patients with non-metastatic Siewert type II/III adenocarcinoma of esophagogastric junction: a prospective cohort study (the AMONP corhort).
    Zhang JW; Huang L; Xu AM
    Oncotarget; 2017 Aug; 8(34):57516-57527. PubMed ID: 28915691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.